Area of research
Rheumatology · Immunology
Research interest
Research interests include Medicine, Ixekizumab, Secukinumab, Ustekinumab, Gastroenterology, and Cancer.
Risk of Infections and Cancer in Patients With Rheumatologic Diseases Receiving Interleukin Inhibitors
A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis